PEY15 LATANOPROST VERSUS TIMOLOL MONOTHERAPY FOR THE TREATMENT OF GLAUCOMA:A COST-EFFECTIVNESS ANALYSIS IN SCANDINAVIA AND THE UK USING A DECISION-ANALYTIC HEALTH ECONOMIC MODEL

Autor:	JA Stewart, WC Stewart, MA Mychaskiw
Rok vydání:	2006
Předmět:	medicine.medical_specialty business.industry Health Policy Public Health Environmental and Occupational Health Timolol Glaucoma medicine.disease chemistry.chemical_compound chemistry Ophthalmology Medicine Optometry Latanoprost business medicine.drug
Zdroj:	Value in Health. 9:A370
ISSN:	1098-3015
DOI:	10.1016/s1098-3015(10)63721-7
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c4ff47f8e77833821ba3398fafedde4 https://doi.org/10.1016/s1098-3015(10)63721-7 Zobrazit plný text záznamu Full Text from ScienceDirect Plný text